Thread by @Biff248824

🚨Call to action on Novavax & COVID vaccination as a whole:

The CDC’s Advisory Committee on Immunization Practices (ACIP) is meeting this week, and they’ve signaled their intentions to shift to a risk-based approach to COVID vaccines, to limit childhood access to COVID vaccines, and to recommend a bivalent COVID vaccine (now clear this is their game plan on continuing to sideline Novavax)

Here is the full livestream of yesterday’s ACIP meeting (04/15/2025):
m.youtube.com/live/dNCVr9AvF…

Here is the full livestream of today’s ACIP meeting (04/16/2025):
m.youtube.com/watch?v=zN4ACg…

CNN: CDC considers narrowing its Covid-19 vaccine recommendations:
cnn.com/2025/04/16/hea…

Here is a portion of the meeting where they talk about Moderna’s “new” next gen bivalent vaccine, mRNA-1283, which shows a very low efficacy of 38% and is the exact same thing that we already used in the 2022-2023 vaccination season with limited success:
youtube.com/live/dNCVr9AvF…

**Contact the ACIP members to voice your displeasure with the direction that the committee is moving.**

Helpful talking points:

1. Support to maintain broad recommendations for all ages, recommend updated COVID shots every 6 months, and that a risk-based approach is dangerous.

2. As shown in studies, monovalent shots are far superior to bivalent shots, and we’ve already experienced the shortcomings of a bivalent shot in the 2022-2023 vaccine season.

3. Novavax should receive full approval of their Biologics License Application (BLA), should be approved for pediatric access, and the shelf life should be extended to keep April doses on the shelves through spring & summer.

Here are the email contacts for the voting members of ACIP:
[e-mail]
[e-mail]
[e-mail]
[e-mail]
[e-mail]
[e-mail]
[e-mail]
[e-mail]
[e-mail]
[e-mail]
[e-mail]
[e-mail]
[e-mail]
[e-mail]
[e-mail]
[e-mail]
[e-mail]
[e-mail]
[e-mail]